ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
Recently, the SARS-CoV-2 induced disease COVID-19 has spread all over the world. Nearly 20% of the patients have severe or critical conditions. SARS-CoV-2 exploits ACE2 for host cell entry. ACE2 plays an essential role in the renin–angiotensin–aldosterone system (RAAS), which regulates blood pressur...
Main Authors: | Li Xiao, Hiroshi Sakagami, Nobuhiko Miwa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/5/491 |
Similar Items
-
Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
by: Jairo Lumpuy-Castillo, et al.
Published: (2020-09-01) -
A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era
by: Speranza Rubattu, et al.
Published: (2021-07-01) -
Relationship between ENaC Regulators and SARS-CoV-2 Virus Receptor (ACE2) Expression in Cultured Adult Human Fungiform (HBO) Taste Cells
by: Mehmet Hakan Ozdener, et al.
Published: (2022-06-01) -
A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets
by: Pia V. Sodhi, et al.
Published: (2022-12-01) -
How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis
by: Fabio Panariello, et al.
Published: (2020-11-01)